HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshiro Matsui Selected Research

tryptophyl-histidine

7/2015The Anti-atherosclerotic Dipeptide, Trp-His, Reduces Intestinal Inflammation through the Blockade of L-Type Ca2+ Channels.
1/2012The anti-atherosclerotic di-peptide, Trp-His, inhibits the phosphorylation of voltage-dependent L-type Ca(2+) channels in rat vascular smooth muscle cells.
11/2010Trp-His, a vasorelaxant di-peptide, can inhibit extracellular Ca2+ entry to rat vascular smooth muscle cells through blockade of dihydropyridine-like L-type Ca2+ channels.
2/2010Vasodilating dipeptide Trp-His can prevent atherosclerosis in apo E-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshiro Matsui Research Topics

Disease

7Inflammation (Inflammations)
10/2019 - 01/2011
6Atherosclerosis
11/2021 - 06/2003
6Colitis
01/2021 - 11/2012
5Neoplasms (Cancer)
01/2020 - 06/2003
4Hypertension (High Blood Pressure)
12/2017 - 10/2002
3Glucose Intolerance
10/2019 - 08/2015
3Body Weight (Weight, Body)
07/2015 - 02/2010
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021 - 02/2017
2Breast Neoplasms (Breast Cancer)
01/2020 - 10/2018
2Cognitive Dysfunction
01/2020 - 08/2018
2Prediabetic State (Prediabetes)
09/2017 - 08/2015
2Weight Loss (Weight Reduction)
02/2015 - 11/2012
1Atherosclerotic Plaque (Atheroma)
11/2021
1Atrophy
09/2021
1Muscular Atrophy (Muscle Atrophy)
09/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2020
1Type 2 Diabetes Mellitus (MODY)
10/2019
1Cardiovascular Diseases (Cardiovascular Disease)
10/2019
1Hypercholesterolemia
12/2017
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
02/2017
1Insulin Resistance
11/2016
1Edema (Dropsy)
11/2014
1Bacterial Infections (Bacterial Infection)
01/2012
1Fatty Liver
01/2010
1Obesity
06/2003

Drug/Important Bio-Agent (IBA)

7Peptides (Polypeptides)IBA
09/2021 - 11/2006
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
02/2017 - 02/2015
4Dextrans (Dextran)FDA Link
02/2017 - 02/2015
4tryptophyl-histidineIBA
07/2015 - 02/2010
3Pyruvaldehyde (Methylglyoxal)IBA
10/2019 - 08/2015
3Blood Glucose (Blood Sugar)IBA
09/2017 - 08/2015
3CytokinesIBA
07/2015 - 11/2012
2AcidsIBA
01/2020 - 01/2010
2Proteins (Proteins, Gene)FDA Link
10/2019 - 06/2018
2Advanced Glycation End ProductsIBA
10/2019 - 09/2017
2imidazoloneIBA
09/2017 - 08/2015
2Glucose (Dextrose)FDA LinkGeneric
11/2016 - 08/2015
2DipeptidesIBA
07/2015 - 02/2010
2Biological ProductsIBA
11/2010 - 06/2003
2Antihypertensive Agents (Antihypertensives)IBA
11/2006 - 10/2002
1Phospholipids (Phosphatides)FDA LinkGeneric
11/2021
1LipidsIBA
11/2021
11-penicillamyl-Leu(2)- oxytocinIBA
11/2021
1Ligases (Synthetase)IBA
09/2021
1UbiquitinIBA
09/2021
1PolyvinylsIBA
01/2021
1Phenobarbital (Luminal)FDA Link
01/2021
1Cholecalciferol (Vitamin D3)FDA Link
01/2021
1Butyrates (Butyrate)IBA
01/2021
1Therapeutic UsesIBA
01/2021
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2020
1decanaldehyde (decanal)IBA
01/2020
1caprylic aldehydeIBA
01/2020
1heptanalIBA
01/2020
1AldehydesIBA
01/2020
1Culture MediaIBA
01/2020
1Amyloid beta-PeptidesIBA
01/2020
1cetyl alcoholFDA LinkGeneric
01/2020
1nonanalIBA
01/2020
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2019
1GlyceraldehydeIBA
10/2019
1argpyrimidineIBA
10/2019
1Untranslated RNA (Noncoding RNA)IBA
10/2018
1PolyphenolsIBA
10/2018
1Estrogen ReceptorsIBA
10/2018
1glyceollinIBA
10/2018
1Estrogens (Estrogen)FDA Link
10/2018
1Soybean Proteins (Soy Protein)IBA
08/2018
1Brain-Derived Neurotrophic Factor (BDNF)IBA
08/2018
1RNA (Ribonucleic Acid)IBA
06/2018
1DNA (Deoxyribonucleic Acid)IBA
06/2018
1N(6)-carboxymethyllysine (carboxymethyllysine)IBA
09/2017
1isomaltodextrinIBA
02/2017
1Polysaccharides (Glycans)IBA
02/2017
1AdenineFDA LinkGeneric
06/2016
1NucleotidesIBA
03/2016
1Blood Proteins (Serum Proteins)IBA
08/2015
1Drinking WaterIBA
02/2015
1ConalbuminIBA
02/2015
1CarrageenanIBA
11/2014
1VPY tripeptideIBA
11/2012
1Interleukin-6 (Interleukin 6)IBA
11/2012
1Interleukin-17 (Interleukin 17)IBA
11/2012
1Metalloproteases (Metalloproteinases)IBA
01/2012
1ThermolysinIBA
01/2012
1ZincIBA
01/2012
1Virulence Factors (Pathogenicity Factors)IBA
01/2012
1chungkookjangIBA
01/2011
1SilkFDA Link
06/2010
1Fibroins (Fibroin)IBA
06/2010
1PhytochemicalsIBA
02/2010
1Apolipoproteins E (ApoE)IBA
02/2010
1TeaIBA
01/2010
1Lipase (Acid Lipase)FDA Link
01/2010
1Pharmaceutical PreparationsIBA
11/2006
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2006
1Conjugated Linoleic AcidsIBA
06/2003

Therapy/Procedure

6Oral Administration
01/2021 - 05/2010
2Therapeutics
10/2018 - 11/2012
1Denervation
09/2021